Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review.

Jae Hung JungKaren Ann McCutcheonMichael BorofskyShamar YoungJafar GolzarianMyung Ha KimVikram NarayanPhilippe D Violette

Published in: BJU international (2022)

Compared to TURP, the impact on urological symptoms and QoL improvement as perceived by patients appears to be similar. This review did reveal major uncertainty as to how major adverse events compare.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
physical activity
peritoneal dialysis
genome wide
single cell
dna methylation
middle aged